[1]
V. M, N. K, A. A, and S. M. Siddalingegowda, “Targeting Metabolic Pathways for Neurodegeneration: The Emerging Role of Anti-Diabetic and Lipid-Lowering Agents”, Int. J. of Allied Med. Sci. and Clin. Res., vol. 13, no. 4, pp. 633–642, Nov. 2025.